2576
N. Lachance et al.
PAPER
Method 3: Following the General Procedure II, the reaction of 15
(295 mg, 2.29 mmol), 19 (0.47 mL, 4.53 mmol), PPTS (140 mg,
0.56 mmol), Si(OEt)4 (0.51 mL, 2.28 mmol), Pd(PPh3)4 (139 mg,
0.12 mmol) and pyridine (0.75 mL), heated for 40 min at 160 °C and
after purification [Cy2NMe (0.58 mL); column chromatography:
hexane–EtOAc–Et3N, 9:1:1 → 5:4:1; trituration: heptane], afforded
13 as a white solid (344 mg, 87%); mp 206–208 °C (EtOAc–hep-
tane) (Lit.7 mp 202–203 °C).
at 160 °C, and after purification [column chromatography: CH2Cl2–
MeOH–NH4OH, 99:1:0 → 87:10:3; trituration: 50% CH2Cl2 in hep-
tane], afforded 20 as a white solid (257 mg, 66%); mp 272–274 °C
(acetone) (Lit.8 mp 270–272 °C).
1H NMR: d = 11.11 (s, 1 H), 8.60 (s, 1 H), 8.06 (d, J = 5.5 Hz, 1 H),
7.20 (d, J = 5.5 Hz, 1 H), 2.70–2.64 (m, 4 H), 1.83–1.77 (m, 4 H).
13C NMR: d = 140.0, 139.5, 139.0, 135.6, 124.2, 107.7, 106.0, 22.7,
22.57, 22.55, 20.4.
1H NMR: d = 10.87 (s, 1 H), 8.17 (dd, J = 1.4, 4.6 Hz, 1 H), 7.55
(dd, J = 1.4, 8.0 Hz, 1 H), 6.95 (dd, J = 4.6, 8.0 Hz, 1 H), 2.72 (t,
J = 6.1 Hz, 2 H), 2.67 (t, J = 6.0 Hz, 2 H), 1.86–1.76 (m, 4 H).
MS (ESI): m/z = 173 [M + 1].
Anal. Calcd for C11H12N2: C, 76.71; H, 7.02; N, 16.26. Found: C,
76.61; H, 6.99; N, 16.30.
13C NMR: d = 145.2, 140.9, 138.8, 128.3, 116.8, 115.1, 108.7, 23.0,
22.8, 22.7, 20.0.
Ethyl 5,6,7,8-Tetrahydrocyclopenta[4,5]pyrrolo[3,2-c]pyridin-
6-ylacetate (27)
MS (ESI): m/z = 173 [M + 1].
Anal. Calcd for C11H12N2: C, 76.71; H, 7.02; N, 16.26. Found: C,
76.95; H, 6.76; N, 16.21.
Following the General Procedure III, the reaction of 2126 (496 mg,
2.25 mmol), 24 (786 mg, 4.62 mmol), PPTS (141 mg, 0.56 mmol),
Si(OEt)4 (0.51 mL, 2.28 mmol), and pyridine (0.75 mL) heated suc-
cessively for 20 min at 160 °C, 180 °C, 200 °C and 220 °C, treated
with Pd(PPh3)4 (136 mg, 0.12 mmol) and Cy2NMe (0.62 mL, 2.92
mmol), heated successively for 2 × 20 min (40 min) at 160 °C, and
after purification [column chromatography: hexane–EtOAc–Et3N,
9:1:1 → 0:9:1; trituration: 1% CH2Cl2 in heptane], afforded 27 as a
tan solid (252 mg, 46%); mp 123–124 °C (CH2Cl2–heptane).
5,6,7,8,9,10-Hexahydrocyclohepta[4,5]pyrrolo[3,2-b]pyridine
(14)
Method 1: Following the General Procedure I, the reaction of 816
(509 mg, 2.29 mmol), Pd(PPh3)4 (134 mg, 0.12 mmol), Cy2NMe
(0.58 mL, 2.73 mmol) and pyridine (1.5 mL), heated for 20 min at
160 °C and after purification [column chromatography: hexane–
EtOAc–Et3N, 9:1:1 → 5:4:1; trituration: heptane], afforded 14 as a
white solid (363 mg, 85%).
1H NMR: d = 11.10 (s, 1 H), 8.59 (s, 1 H), 8.06 (d, J = 5.6 Hz, 1 H),
7.29 (d, J = 5.6 Hz, 1 H), 4.10 (q, J = 7.1 Hz, 2 H), 3.56–3.50 (m, 1
H), 2.84–2.68 (m, 4 H), 2.52–2.46 (m, 1 H), 2.16–2.09 (m, 1 H),
1.17 (t, J = 7.1 Hz, 3 H).
Method 2: Following the General Procedure II, the reaction of 15
(299 mg, 2.33 mmol), 1719 (841 mg, 4.51 mmol), Pd(PPh3)4 (141
mg, 0.12 mmol) and pyridine (1.5 mL), heated for 20 min at 160 °C
and after purification [Cy2NMe (0.58 mL); column chromatogra-
phy: hexane–EtOAc–Et3N, 9:1:1 → 5:4:1; trituration: heptane], af-
forded 14 as a white solid (351 mg, 81%); mp 236–238 °C (EtOAc–
heptane).
13C NMR: d = 171.7, 147.0, 144.1, 140.7, 139.3, 120.9, 116.7,
107.4, 60.0, 38.7, 35.5, 34.9, 22.9, 14.1.
MS (ESI): m/z = 245 [M + 1].
Anal. Calcd for C14H16N2O2: C, 68.83; H, 6.60; N, 11.47. Found: C,
68.56; H, 6.32; N, 11.29.
1H NMR: d = 10.88 (s, 1 H), 8.18 (d, J = 4.6 Hz, 1 H), 7.54 (d, J =
8.1 Hz, 1 H), 6.93 (dd, J = 4.6, 8.1 Hz, 1 H), 2.85–2.82 (m, 4 H),
1.87–1.83 (m, 2 H), 1.72–1.62 (m, 4 H).
Ethyl 1H-Pyrrolo[3,2-b]pyridine-2-carboxylate (28)
Following the General Procedure III, the reaction of 15 (291 mg,
2.26 mmol), 25 (0.50 mL, 4.52 mmol), PPTS (141 mg, 0.56 mmol),
Si(OEt)4 (0.51 mL, 2.28 mmol), and pyridine (0.75 mL) stirred for
48 h at r.t., treated with Pd(PPh3)4 (136 mg, 0.12 mmol) and
Cy2NMe (0.62 mL, 2.92 mmol), heated for 20 min at 160 °C, and
after purification [column chromatography: hexane–EtOAc–Et3N,
9:1:1 → 0:9:1; trituration: 10% CH2Cl2 in heptane], afforded 28 as
a white solid (343 mg, 80%); mp 179–181 °C (CH2Cl2–hexane)
(Lit.27 mp 179 °C).
13C NMR: d = 146.1, 142.4, 141.2, 127.0, 117.0, 115.1, 112.9, 31.8,
29.2, 28.6, 27.2, 23.2.
MS (ESI): m/z = 187 [M + 1].
Anal. Calcd for C12H14N2: C, 77.38; H, 7.58; N, 15.04. Found: C,
77.20; H, 7.65; N, 14.95.
6,7,8,9-Tetrahydro-5H-pyrido[4,3-b]indole (20)
Method 1: Following the General Procedure II, the reaction of 16
(391 mg, 2.25 mmol), 18 (0.55 mL, 4.58 mmol), PPTS (61 mg, 0.24
mmol), Pd(PPh3)4 (136 mg, 0.12 mmol) and pyridine (1.5 mL),
heated for 35 h at 160 °C and after purification [Cy2NMe (0.58 mL);
1H NMR: d = 12.14 (s, 1 H), 8.45 (dd, J = 1.3, 4.4 Hz, 1 H), 7.83 (d,
J = 8.3 Hz, 1 H), 7.26 (dd, J = 4.4, 8.3 Hz, 1 H), 7.20 (d, J = 1.3 Hz,
1 H), 4.36 (q, J = 7.1 Hz, 2 H), 1.34 (t, J = 7.1 Hz, 3 H).
column chromatography: CH2Cl2–MeOH–NH4OH, 99:1:0
87:10:3; trituration: 50% CH2Cl2 in heptane], afforded 20 as a pale
yellow solid (104 mg, 27%) and 4-aminopyridine (99 mg, 47%).
→
13C NMR: d = 161.1, 144.6, 144.3, 130.3, 129.8, 120.1, 119.5,
107.2, 60.8, 14.2.
MS (ESI): m/z = 191 [M + 1].
Method 2: Following the General Procedure III, the reaction of 16
(390 mg, 2.25 mmol), 18 (0.55 mL, 4.58 mmol), PPTS (61 mg, 0.24
mmol), and pyridine (1.5 mL) heated successively for 20 min at 160
°C, 180 °C, 200 °C and 220 °C, treated with Pd(PPh3)4 (137 mg,
0.12 mmol) and Cy2NMe (0.62 mL, 2.92 mmol), heated successive-
ly for 4 × 20 min (80 min) at 160 °C, and after purification [column
chromatography: CH2Cl2–MeOH–NH4OH, 99:1:0 → 87:10:3; trit-
uration: 50% CH2Cl2 in heptane], afforded 20 as a white solid (187
mg, 48%).
Anal. Calcd for C10H10N2O2: C, 63.15; H, 5.30; N, 14.73. Found: C,
63.02; H, 5.33; N, 14.42.
Ethyl 1H-Pyrrolo[2,3-c]pyridine-2-carboxylate (29)
Following the General Procedure III, the reaction of 22 (291 mg,
2.26 mmol), 25 (0.50 mL, 4.52 mmol), PPTS (140 mg, 0.56 mmol),
Si(OEt)4 (0.51 mL, 2.28 mmol), and pyridine (0.75 mL) stirred for
48 h at r.t., treated with Pd(PPh3)4 (136 mg, 0.12 mmol) and
Cy2NMe (0.62 mL, 2.92 mmol), heated successively for 2 × 20 min
(40 min) at 160 °C, and after purification [column chromatography:
hexane–EtOAc–Et3N, 9:1:1 → 0:9:1; trituration: 10% CH2Cl2 in
heptane], afforded 29 as a white solid (272 mg, 63%); mp 212–214
°C (toluene) (Lit.28 mp 212–214 °C).
Method 3: Following the General Procedure III, the reaction of 2126
(495 mg, 2.25 mmol), 18 (0.55 mL, 4.58 mmol), PPTS (61 mg, 0.24
mmol), and pyridine (1.5 mL) heated successively for 20 min at 160
°C, 180 °C, 200 °C and 220 °C, treated with Pd(PPh3)4 (137 mg,
0.12 mmol) and Cy2NMe (0.62 mL, 2.92 mmol), heated for 20 min
Synthesis 2005, No. 15, 2571–2577 © Thieme Stuttgart · New York